The next Rx-to-OTC switch is likely to be Sanofi-Aventis’ Allegra.
The next Rx-to-OTC switch is likely to be Sanofi-Aventis’ Allegra.
Credit: 
3207DSN_OverTheCounter5-fig1.jpg